FDA May Need More Funding To Keep Pace With NIH, Crawford Says
FDA may need to ask for supplemental funding to keep pace with applications expected to result from the National Institutes of Health's recent funding increase, Deputy Commissioner Lester Crawford, PhD, said
You may also be interested in...
House Appropriations/Agriculture Subcommittee Ranking Democrat Kaptur (D-Ohio) is requesting information from FDA on the impact of increased research spending at the National Institutes of Health.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials